Article: Genentech gains on Amgen

Article: "Big Pharma' Turns To Biologics For Growth To 2010: Financial And Strategic Segmentation Of The 'Big Pharma' Sector By Drug Technology" by Datamonitor.
M2 Presswire;  June 5, 2006 ;     403 words ......2006-MindBranch: Big Pharma' Turns To Biologics...Segmentation Of The 'Big Pharma' Sector By Drug...RDATE:02062006 'Big Pharma' (non-biotech companies...forecasts for all Big Pharma products, split...relationship with Genentech, and Novartis' ...

Article: Big pharma ex-growth.
Investors Chronicle - magazine and web content;  December 17, 2007 ;     323 words ...Themes for 2008: Big pharma stocks now look like yield plays rather...1990s the ethos was merge or die and big pharma got even bigger. The last wave of...consequent threat from generic drugs. Big pharma is also extremely vulnerable to health...

Article: As blockbusters fade, Big Pharma "must change or perish," warns US analyst.
Pharma Marketletter;  January 3, 2005 ;     700+ words ......business model of blockbuster drugs used by Big Pharma needs to be revisited, Sander Flaum of...formularies will be tighter after 2005. For Big Pharma it is change or perish, he said; no...margins and little competition, he said. Big Pharma has changed its tactics before and will...

Article: I Love Big Pharma
Winnipeg Free Press;  January 20, 2008 ;     700+ words ......Baker I have a confession to make. I like Big Pharma. I actually like all those evil transnational...drama, murder and mayhem to discredit Big Pharma, which he claims operates with "pathological...They simply save the same lives that Big Pharma could save, but at a fraction of the...

Article: Cover Story: Global Outlook - Pharma - Big pharma gets bigger.
Foreign Direct Investment;  April 1, 2009 ;     700+ words ...Byline: Lara Williams Big pharma is getting bigger. A wave...economic slowdown - and big pharma's response is to diversify...successful $47bn bid for Genentech in March followed an eight-mon...Improving efficiencies Despite big pharma's strong cash flows and...geographical reach ...

Article: Research and Markets: Excellent Resource for Serious Players Who Would Like to Understand the Current Competitive Field in Cancer Drug Development Among Big Pharma and Relate to It.
PR Newswire;  April 27, 2005 ;     442 words ......buck stops for most at the doorstep of big pharma companies. Fortunately, in spite of major mergers among big pharma, there is plenty of competitive space...companies to choose with whom in the big pharma industry to partnership with. This...

Article: Big pharma: too cheap to pass up: everyone, it seems, hates the drug industry. That makes this sector a contrarian's dream.(INVESTING)(Pfizer Inc., Merck and Company Inc., and Bristol-Myers Squibb Co.)
Kiplinger's Personal Finance Magazine;  July 1, 2008 ;     700+ words ...BIG PHARMA IS IN NEED OF a miracle cure. The major...good signs, such as strong cash flow. Big Pharma also has something that smaller, more...both like Pfizer, the poster child for Big Pharma's problems. Their position is essentially...

Article: Big Pharma Is Missing the Nanotechnology Opportunity; Lux Research report finds that pharmaceutical giants invest less money and people in nanotech than other industries - despite pressure to replace fading blockbuster drugs.
PR Newswire;  February 15, 2005 ;     700+ words ......report from Lux Research entitled Why Big Pharma Is Missing the Nanotech Opportunity...President of Research Matthew M. Nordan. But big pharma is not investing in nanotech today. If...in other electronics and materials. * Big pharma companies on average commit 16 people...

Article: Clearview Projects Sponsers BioPartnering Europe Conference; Sam Barker, CEO, Chairs Panel Session 'Strategic Partnering: The Evolving Interdependence of Big Pharma and Biotech'.
PR Newswire;  October 7, 2003 ;     499 words ......Partnering: The Evolving Interdependence of Big Pharma and Biotech on October 13. Joining Dr...Development, Boehringer Ingelheim GmbH. Big pharma is increasingly turning to biotech to...strategic partnerships between biotech and big pharma have always been important, they have...

Article: Bush And Big Pharma: Agenda Still To Eliminate Cross Border Trade, Says DoctorSolve; President Bush might not have said so, but he supports Big Pharma's agenda to prevent prescription drug importation from Canada.
PR Newswire;  February 3, 2005 ;     534 words ......speaks volumes about his loyalties to Big Pharma and its agenda to eliminate drugs imported...that he really supports the interests of Big Pharma, says Dr. Paul Zickler, co-founder of...recent events, there is no doubt that Big Pharma and its hired help will go to any length...

Article: Big pharma has left it too late - Shire.
Investors Chronicle - magazine and web content;  December 11, 2008 ;     657 words ......The era of the blockbuster is over, but big pharma is still stuck in it, the chief executive...in an exclusive interview The era of big pharma is drawing to a close, according to smaller...alternative business model. As I see it, big pharma are shedding sales staff as fast as they...

Article: Big pharma shares suffer; andrew miller In association with RBS.(Business)
The Journal (Newcastle, England);  September 12, 2007 ;     571 words ......struggling. In recent years, so-called big pharma has not proved a particularly good investment...patent expirations. Other factors make big pharma - and investors in it - particularly...although probably not fast enough. But big pharma's well-publicised problems do not mean...

Article: Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus on Leukemias and Lymphomas.
M2 Presswire;  February 14, 2008 ;     562 words ......2008-Research and Markets: Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus on...announced the addition of Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus on...the report for professionals interested to grasp big ...

Article: Life After Big Pharma?
Pharmaceutical Executive;  April 1, 2005 ;     700+ words ......asking themselves, Is There Life After Big Pharma? Stephen Israel, who manages the biotech...companies. Pharm Exec: Why do you think Big Pharma marketing execs may eventually end up...to have come from the discipline of a Big Pharma company and who have P&L experience-peop...